ZBTB24 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.573600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.949600E-02
Normal-vs-Stage2
2.555600E-01
Normal-vs-Stage3
2.050400E-01
Normal-vs-Stage4
3.097800E-01
Stage1-vs-Stage2
6.493800E-01
Stage1-vs-Stage3
2.438600E-01
Stage1-vs-Stage4
3.897000E-01
Stage2-vs-Stage3
4.495600E-01
Stage2-vs-Stage4
1.626650E-01
Stage3-vs-Stage4
6.516500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.579000E-01
Normal-vs-AfricanAmerican
1.499950E-01
Normal-vs-Asian
2.209000E-01
Caucasian-vs-AfricanAmerican
5.384000E-01
Caucasian-vs-Asian
3.314800E-01
AfricanAmerican-vs-Asian
2.859000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.494800E-01
Normal-vs-Female
2.700200E-01
Male-vs-Female
4.067400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.677800E-01
Normal-vs-Age(41-60Yrs)
2.881200E-01
Normal-vs-Age(61-80Yrs)
2.458000E-01
Normal-vs-Age(81-100Yrs)
2.362000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.706800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.660600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.702200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.271360E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.211980E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.853800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.335400E-01
Normal-vs-Daily Drinker
2.063400E-01
Normal-vs-Weekly Drinker
2.310600E-01
Normal-vs-Occasional Drinker
2.600200E-01
Normal-vs-Social Drinker
6.776400E-02
Non Drinker-vs-Daily Drinker
4.007000E-01
Non Drinker-vs-Weekly Drinker
9.196000E-01
Non Drinker-vs-Occasional Drinker
4.837200E-01
Non Drinker-vs-Social Drinker
3.584200E-01
Daily Drinker-vs-Weekly Drinker
5.104400E-01
Daily Drinker-vs-Occasional Drinker
9.074400E-02
Daily Drinker-vs-Social Drinker
1.916820E-01
Weekly Drinker-vs-Occasional Drinker
4.344600E-01
Weekly Drinker-vs-Social Drinker
4.139000E-01
Occasional Drinker-vs-Social Drinker
7.065000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.941600E-01
Normal-vs-Grade 2
2.630000E-01
Normal-vs-Grade 3
2.207600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.614400E-01
Grade 1-vs-Grade 3
8.715600E-01
Grade 1-vs-Grade 4
3.941600E-01
Grade 2-vs-Grade 3
7.555400E-01
Grade 2-vs-Grade 4
2.630000E-01
Grade 3-vs-Grade 4
2.207600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.510000E-01
Normal-vs-NonDiabetic
2.398400E-01
Diabetic-vs-NonDiabetic
6.853400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.943350E-01
Normal-vs-NoPancreatitis
2.535200E-01
Pancreatitis-vs-NoPancreatitis
2.859000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.724000E-01
Normal-vs-N1
2.527200E-01
N0-vs-N1
4.928000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.652600E-01
Normal-vs-TP53-NonMutant
3.636600E-01
TP53-Mutant-vs-TP53-NonMutant
1.448390E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
